The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 02, 2024
Filed:
Jan. 10, 2020
Applicant:
Expres2ion Biotechnologies Aps, Hørsholm, DK;
Inventors:
Stine Broch Clemmensen, Hørsholm, DK;
Teit Max Moscote Søgaard, Kokkedal, DK;
Willem Adriaan De Jongh, Holte, DK;
Assignee:
EXPRES2ION BIOTECHNOLOGIES APS, Hørsholm, DK;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/00 (2006.01); A61K 38/17 (2006.01); A61K 39/39 (2006.01); A61P 31/14 (2006.01); C07K 14/71 (2006.01); C12N 9/10 (2006.01); C12N 15/81 (2006.01); C12N 15/85 (2006.01); C12P 21/00 (2006.01);
U.S. Cl.
CPC ...
A61K 39/001106 (2018.08); A61K 38/1741 (2013.01); A61K 39/39 (2013.01); A61P 31/14 (2018.01); C07K 14/71 (2013.01); C12N 9/1051 (2013.01); C12N 15/815 (2013.01); C12N 15/85 (2013.01); C12P 21/005 (2013.01); C12Y 204/01152 (2013.01); A61K 2039/5258 (2013.01); C12Y 204/01065 (2013.01);
Abstract
Disclosed are immunization antigens that have been glyco-engineered to include non-native glycosylation patterns with a view to enhance their properties as antigens for use in such areas as vaccination and antibody production. Also disclosed are to means and methods for producing the glycomodified antigens as well of methods and uses of the glycomodified antigens.